- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT02699814
H3: Healthy Minds, Healthy Children, Healthy Chicago Project Evaluation (H3)
The goal of this project is to develop and pilot test a community-based integrated care model to improve the prevention, early detection and treatment of child mental health problems that is replicable, effective, and sustainable. Project procedures include child mental health screening, on-site brief mental health interventions, referral to specialty mental health, use of co-located child psychiatrist, detection of need for primary care in specialty mental health program. Subjects will be enrolled for 1 year, with interviews at baseline and 3, 6 and 12 months.
Dr. Bonnie Zima at UCLA has been contracted by the project funder to design and implement the evaluation of the project, which includes developing data collection procedures, training staff on implementation of data collection workflow, coordinating with sites to ensure evaluation design and IRB protocols are followed, and coordinating with both study sites to verify data reliability.
Some potential anticipated risks include being uncomfortable answering questions associated with the measures used in the study, and although unlikely, someone may access participant information that is confidential. Some benefits include helping to find ways to improve how to deliver mental health care for children served in publicly-funded primary care and mental health clinics.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
UCLA is in charge of the evaluation of the H3 project, including evaluation design and overseeing data collection by project sites. UCLA will receive data collected by each site and perform the analysis of the data for the sites to be shared with the Illinois Children's Healthcare Foundation and clinic sites. This study will evaluate an existing intervention, meaning that participation in the evaluation is not required in order to receive H3 services.
The information below is included in the evaluation design document attached in 10.1, 1.0:
The overarching goal of the Healthy Minds, Healthy Children, Healthy Chicago Initiative (H3) is to develop a community-based integrated care model to improve the prevention, early detection and treatment of child mental health problems that is replicable, effective, and sustainable.
The final study design is a longitudinal cohort study of 400 children ages 0-17 years and their families served at the two intervention clinic sites (n=200/site) The study time points are baseline, 3-, 6-, and 12-months.
The data sources are parent and youth report, and clinic administrative data when feasible for the programs to transfer these data following IRB-approved procedures. The unit of analysis is the child. The main proximal (or short term) clinical outcomes are related to the H3 intervention care processes (e.g., brief mental health interventions, referral to specialty mental health care, co-located child psychiatrist). The time period will likely vary by child depending on clinical need, but it is anticipated that most of these care processes will be provided during the early phase when the child and parent is introduced to the new care model. The main distal outcomes (or more long-term) are clinical improvement (e.g., child symptom reduction, improved functioning) and some correspond to the care process delivered (e.g., if parent receives parent training, improvement parenting skills are assessed). The time points for tracking clinical improvement are 3, 6 and 12 months after the baseline interview that is done when the parent and child are enrolled in the evaluation. The independent variables (or factors that may influence care processes and clinical outcomes) are child sociodemographic characteristics (e.g. age, sex, race/ethnicity), psychosocial complexity, and primary caregiver characteristics that the clinic team or Community Advisory Board deemed relevant (e.g., parenting stress, probable depression). Embedded within the description of a child's psychosocial complexity are indicators of social determinants (e.g. exposure to trauma) that may adversely impact a child's development and well-being.
Findings from this evaluation will provide data on the acceptability and feasibility of the H3 care models, as well as early indicators of whether these care models are promising.
Studietyp
Inskrivning (Faktisk)
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
Illinois
-
Chicago, Illinois, Förenta staterna, 60621
- Miles Square Health Center, Englewood
-
Chicago, Illinois, Förenta staterna, 60622
- Erie Family Health Center, West Town
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- between the ages of 0.0-16.99 years
- speaks Spanish or English
- screens positive for a developmental delay or mental health problem
- referral to the H3 care program by a pediatrician based on clinical judgment
- no prior history of receiving any H3 services in the past year
Exclusion Criteria (based on the child's characteristics):
- 17 years old (to avoid reconsent at 12 month follow-up)
- has previously had H3 services in the past year
- can not speak English or Spanish
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Hälsovårdsforskning
- Tilldelning: N/A
- Interventionsmodell: Enskild gruppuppgift
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
---|---|
Experimentell: H3 Parent/Child Dyads
A child is eligible for the H3 partnered evaluation if he or she is: 1) between the ages of 0.0-16.99
years; 2) speaks Spanish or English; 3) screens positive for a developmental delay or mental health problem.
For children in the intervention groups, the additional eligibility criteria are: 1) referral to the H3 care program by a pediatrician based on clinical judgment; and 2) no prior history of receiving any H3 services in the past year.
|
A community-based integrated care model to improve the prevention, early detection and treatment of child mental health problems
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
H3 intervention care processes
Tidsram: 12 months
|
tracking administration (yes/no) of "brief mental health interventions", "referral to specialty mental health care", "use of co-located child psychiatrist", "detected need for primary care"
|
12 months
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Mental health functioning
Tidsram: Baseline, 3, 6 and 12 months
|
PHQ9
|
Baseline, 3, 6 and 12 months
|
Child development
Tidsram: 12 monthsBaseline, 3, 6 and 12 months
|
Pediatric Symptom Checklist
|
12 monthsBaseline, 3, 6 and 12 months
|
Child functioning
Tidsram: Baseline, 3, 6 and 12 months
|
Columbia Impairment Scale
|
Baseline, 3, 6 and 12 months
|
Response to trauma and resilience
Tidsram: Baseline, 3, 6 and 12 months
|
Traumatic Events Screening Inventory
|
Baseline, 3, 6 and 12 months
|
Care process delivered
Tidsram: Baseline, 3, 6 and 12 months
|
Questionnaire administered at baseline, 3, 6, and 12 months asking parent and child about any care processes that he/she received.
|
Baseline, 3, 6 and 12 months
|
Samarbetspartners och utredare
Samarbetspartners
Utredare
- Huvudutredare: Bonnie Zima, MD, MPH, University of California, Los Angeles
Publikationer och användbara länkar
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- IRB#15-000757
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Psykisk sjukdom
-
Hospital Miguel ServetRekrytering
-
Hospital Miguel ServetRekryteringMental Health WellnessSpanien
-
Universidad Nacional de Educación a DistanciaUniversidad Rey Juan Carlos; Ministerio de Ciencia e Innovación, SpainAvslutadMental Health WellnessSpanien
-
Hospital Miguel ServetAktiv, inte rekryterande
-
Chinese University of Hong KongAvslutad
-
Zayed UniversityOkändSova | Mental Health WellnessFörenade arabemiraten
-
Colorado State UniversityUniversity of Colorado, Denver; United States Department of Agriculture... och andra samarbetspartnersRekryteringMental Health Wellness | Livsstilsriskminskning | FamiljeforskningFörenta staterna
-
Wake Forest University Health SciencesHar inte rekryterat ännu
-
Transcultural Psychosocial Organization NepalKing's College LondonHar inte rekryterat ännu
-
Hospital Miguel ServetAktiv, inte rekryterandeMental Health WellnessSpanien
Kliniska prövningar på H3 Services
-
Sanofi Pasteur, a Sanofi CompanyAvslutad
-
Sanofi Pasteur, a Sanofi CompanyAvslutadFriska volontärer | InfluensavaccinationFörenta staterna
-
DT MedTech, LLCRekryteringArtros Ankel | Posttraumatisk artros i fotleden | Artros i fotleden sekundärt till inflammatorisk artrit (störning)Förenta staterna
-
St. Jude Children's Research HospitalRekryteringGlioblastom | Neoplasmer i centrala nervsystemet | Höggradig Gliom | Ependymom | Medulloblastom | Diffus mittlinjegliom, H3 K27M-mutant | Atypisk teratoid/rhabdoid tumörFörenta staterna
-
UNC Lineberger Comprehensive Cancer CenterHar inte rekryterat ännuBukspottkörtelcancer | Återfall | Resistent cancerFörenta staterna
-
Beijing Tiantan HospitalRekrytering
-
PersonGen BioTherapeutics (Suzhou) Co., Ltd.RekryteringÅterfall/refraktär Akut Myeloid LeukemiKina
-
PersonGen BioTherapeutics (Suzhou) Co., Ltd.Tianjin Medical University Cancer Institute and Hospital; Shandong Cancer...RekryteringB7-H3-positivt återfall/refraktärt neuroblastomKina
-
PersonGen BioTherapeutics (Suzhou) Co., Ltd.RekryteringÅterfall/refraktär Akut Myeloid LeukemiKina
-
Second Affiliated Hospital of Soochow UniversitySoochow T-Maximun Biotechnology Co. LTDRekryteringAvancerat gliom | Komplikation av Chimeric Antigen Receptor (CAR-T) cellterapiKina